Skip to search formSkip to main contentSkip to account menu

Dopacard

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

dopexamine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
dopéxamine: Tonicardiaque ou agent inotrope : sympathomimétique – Dopacard®
2004
2004
Einfluss von niedrig-dosiertem Dopexamin auf die Gewebeperfusion im Magenschlauch des Schweines
This experimental setting investigates the influence of dopexamine-hydrochloride (DOPACARD®, Medeus Pharma GmbH, Deutschland) on… 
Review
1996
Review
1996
[High-risk surgical patients. Who are they and how should they be treated?].
This review addresses the currently available information that describes the identification of high risk patients undergoing… 
1996
1996
Dopexamine (dopacard, Speywood).
1994
1994
Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs
Dopexamine hydrochloride (Dopacard®) is the novel synthetic catecholamine designed for use in the acute management of a low… 
1988
1988
Use of dopexamine hydrochloride in intensive care patients with low-output left ventricular heart failure.
1988
1988
Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure.
Dopexamine hydrochloride (Dopacard) is a new synthetic catecholamine compound, which possesses potent beta 2-adrenergic and DA1… 
1988
1988
A symposium: Focus on heart failure--current experiences in basic research and clinical studies on dopexamine hydrochloride (Dopacard). September 12-13, 1987, Paris, France. Proceedings.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)